Home > Financial Ratios > TRIDENT LIFELINE

TRIDENT LIFELINE
Core EBITDA Growth

    Back to All Ratios
TRIDENT LIFELINE is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for TRIDENT LIFELINE
Please provide your vote to see the results

TRIDENT LIFELINE Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) 125.4238.82124.29-

What is the latest Core EBITDA Growth ratio of TRIDENT LIFELINE ?

The latest Core EBITDA Growth ratio of TRIDENT LIFELINE is 125.42 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025125.42
Mar202438.82
Mar2023124.29
Mar2022-

How is Core EBITDA Growth of TRIDENT LIFELINE Trending?

Years Core EBITDA Growth % Change
Mar2025 125.42
223.08
Mar2024 38.82
-68.77
Mar2023 124.29
0
Mar2022 0 -

Other Financial Ratios of TRIDENT LIFELINE


Compare Core EBITDA Growth ratio of peers of TRIDENT LIFELINE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TRIDENT LIFELINE ₹365.4 Cr 4.7% 4.8% 11.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,419.0 Cr 3.5% 6.2% -4.2% Stock Analytics
DIVIS LABORATORIES ₹172,857.0 Cr -2.7% -0.7% 11% Stock Analytics
TORRENT PHARMACEUTICALS ₹129,953.0 Cr 0.6% 9.1% 19.7% Stock Analytics
CIPLA ₹123,722.0 Cr 1.2% -1.4% -4.1% Stock Analytics
DR REDDYS LABORATORIES ₹103,906.0 Cr 3.9% 0.6% -3.7% Stock Analytics


TRIDENT LIFELINE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TRIDENT LIFELINE

4.7%

4.8%

11.9%

SENSEX

1.6%

2.7%

6.3%


You may also like the below Video Courses